Highlights

Share

Program Content

Activities

  • IAS 2021: Key Studies
    What to Expect at the 11th IAS Conference on HIV Science, July 18-21, 2021: A Look at Key Studies
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 19, 2021

    Expires: July 18, 2022

  • WHO Study: COVID-19 and HIV
    The WHO Global Clinical Platform Study: People With HIV and COVID-19
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 20, 2021

    Expires: August 19, 2022

  • IAS 2021—Audio Recap
    Key Studies Influencing My Practice Following IAS 2021—Audio Recap
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 19, 2021

    Expires: August 18, 2022

  • Conference Conversations for Pharmacists
    Conference Conversations: Pharmacist Perspectives From IAS 2021
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 23, 2021

    Expires: August 22, 2022

  • Slides: IAS 2021
    Key Studies Influencing My Practice Following IAS 2021
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2021

    Expires: August 04, 2022

Activities

TANGO Post-Hoc Analysis
TANGO: Post-Hoc Analysis of Viral Replication for 2-Drug DTG/3TC Regimen vs 3- or 4-Drug TAF-Based Regimen Through Week 96
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2021

Expires: July 21, 2022

FLAIR
FLAIR: Week 124 Results of Long-Acting Injectable Cabotegravir + Rilpivirine
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 21, 2021

Expires: July 20, 2022

Protocol 011 Week 96 Safety Analysis
Phase IIb Protocol 011 Safety Analysis at Week 96: Islatravir Plus Doravirine Following Islatravir, Doravirine, Lamivudine Induction
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 20, 2021

Expires: July 19, 2022

DTG in CALHIV
Outcomes of Dolutegravir Use in Children and Adolescents Living With HIV-1 in Sub-Saharan Africa
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2021

Expires: July 21, 2022

CUSTOMIZE
CUSTOMIZE: Implementation-Effectiveness Study of Long-Acting Cabotegravir and Rilpivirine Injection in US Healthcare Settings
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2021

Expires: July 21, 2022

ZeNix
ZeNix: Pretomanid, Bedaquiline, and Varied Doses and Durations of Linezolid in Highly Resistant TB
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2021

Expires: July 25, 2022

CALIBRATE Interim Results
CALIBRATE: Interim Week 28 Results of Long-acting Subcutaneous Lenacapavir in Treatment-Naive Patients
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2021

Expires: July 23, 2022

REACH
REACH: Adherence to Dapivirine Vaginal Ring and Oral PrEP Among Adolescent Girls and Young Women in Africa
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2021

Expires: July 23, 2022

GEMS: PrEP and Resistance
GEMS: ART Resistance in Persons Diagnosed With HIV After PrEP Rollout in Sub-Saharan Africa
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2021

Expires: July 23, 2022

CAPELLA
CAPELLA: Week 26 Results of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced Patients
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2021

Expires: July 21, 2022

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner